Sleep Stimulation to Enhance Waste Clearance in the Brain

Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18-80
SponsorErasme University Hospital

About this trial

This study aims to examine whether multi-night closed-loop auditory stimulation (CLAS) during sleep can enhance waste clearance and memory consolidation in healthy adults and older adults with subjective cognitive decline or mild cognitive impairment who exhibit elevated brain amyloid levels identified through prior clinical screening. Specifically, the study investigates whether sleep stimulation increases the clearance of plasma biomarkers related to neurodegeneration, improves the brain's waste clearance system, and supports memory consolidation. Participants will undergo five nights each of CLAS and sham (no stimulation) interventions, with a washout period in between. They will also complete clinical assessments, including MRI scans, blood sample collection, and cognitive testing, and will keep track of subjective sleep quality, sleepiness, mood, and fatigue throughout the interventions.

Eligibility criteria

This trial accepts healthy volunteers

Qualifiers

Proficiency in the French language (close to native level) to complete the neuropsychological evaluation and cognitive tests.

MRI compatibility: absence of metallic materials in the body (implants, vascular clips, certain types of orthopedic material, etc.), a pacemaker or other types of stimulators, cochlear implants, or any other electronic devices.

Disqualifiers

Current or past psychiatric or neurological conditions (except for those directly associated with the patient group).

The presence of severe untreated sleep disorders.

The presence of irregular sleep-wake cycles (due to shiftwork or extreme chronotype).

The presence of moderate depression or high levels of anxiety.

Trial design

Design model

Crossover

Treatments tested in this trial

  • Closed-loop acoustic stimulation

    Other intervention

    At-home sleep will be monitored using an EEG headband. Non-awakening auditory stimuli will be delivered during non-rapid eye movement sleep (NREM), timed to the ascending phase of slow waves, using either active or control (sham) conditions.

Treatment groups

105 Participants
are divided into 6 treatment groups

6

Treatment groups

See each treatment group below.

Group A: Healthy young, auditory stimulation, then shamExperimental treatment 1 intervention
Group B: Healthy young, sham, then auditory stimulationExperimental treatment 1 intervention
Group C: Healthy old, auditory stimulation, then shamExperimental treatment 1 intervention
Group D: Healthy old, sham then auditory stimulationExperimental treatment 1 intervention
Group E: Positive amyloid load group, auditory stimulation, then shamExperimental treatment 1 intervention
Group F: Positive amyloid load group, sham, then auditory stimulationExperimental treatment 1 intervention

Trial outcomes

Primary outcomes

1

Plasma biomarkers

Levels of plasma biomarkers associated with neurodegeneration and brain health will be compared between stimulation and sham interventions.

Time frame
Blood samples will be collected the morning after each intervention phase. Interventions are separated by one week.

Secondary outcomes

1

Glymphatic function

Magnetic resonance imaging (MRI) derived measures will serve as proxies for glymphatic function and will be compared between stimulation and sham interventions.

Time frame
MRI scans will be performed the morning after each intervention phase. Interventions are separated by one week.
2

CLAS evoked responses

EEG responses locked to the acoustic stimulation will be examined (phase, amplitude, power, slow oscillations, spindle coupling) during stimulation and sham night recordings. Associations between APOE phenotype, age, amyloid accumulation, brain structure and function, baseline memory performance, sleep quality and responses to CLAS will be evaluated.

Time frame
Each night of sleep during each intervention phase, whether receiving stimulation or sham.
3

Slow wave activity (SWA)

EEG SWA will be assessed during NREM sleep periods from each intervention (stimulation and sham)

Time frame
Each night of sleep during each intervention phase, whether receiving stimulation or sham.
4

Sleep architecture

As measured with the EEG headband, macro- (e.g., duration, latency, distribution of sleep stages), and micro-architecture (slow waves, sleep spindles, rapid eye movements, arousals) differences between stimulation and sham conditions will be assessed.

Time frame
Each night of sleep during each intervention phase, whether receiving stimulation or sham.

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.

Erasme University Hospital

Lead sponsor

University of Amsterdam

Collaborator

This trial is not recruiting at the moment. You can still explore other options: